# Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age

> **NCT00808444** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 466 (actual)

## Conditions studied

- Infections, Streptococcal

## Interventions

- **BIOLOGICAL:** Pneumococcal conjugate vaccine GSK1024850A (different lots)
- **BIOLOGICAL:** Infanrix hexa
- **BIOLOGICAL:** Infanrix-IPV/Hib
- **BIOLOGICAL:** Rotarix

## Key facts

- **NCT ID:** NCT00808444
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01-05
- **Primary completion:** 2009-11-02
- **Final completion:** 2009-11-02
- **Target enrollment:** 466 (ACTUAL)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00808444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00808444, "Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00808444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*